new medicines

Breast cancer experts are cheering what could be some of the biggest advances in more than a decade: two new medicines that significantly delay the time until women with very advanced cases get worse.

(Institut Pasteur Korea) Institut Pasteur Korea has signed an agreement with sanofi-aventis Research and Development of Toulouse, France, to continue research on the identification of new medicines.The partnership, extending an agreement drawn up in the fall of 2009, illustrates the value of IP-K's PhenomicScreen to the pharmaceutical industry.

The technology platform will be used to pinpoint active, non-toxic agents in sanofi-aventis' proprietary chemical compound library.

(The Translational Genomics Research Institute) In an industry that faces increasing challenges in delivering new drugs to patients, Predictive Biomarker Sciences today announced three new contracts aimed at bringing new medicines to the marketplace.

P { MARGIN-TOP: 0px; MARGIN-BOTTOM: 0px } BODY { SCROLLBAR-ARROW-COLOR: #3f52b8; SCROLLBAR-DARKSHADOW-COLOR: #fafafa; SCROLLBAR-BASE-COLOR: #f7f7f7; SCROLLBAR-HIGHLIGHT-COLOR: #cecfce; SCROLLBAR-TRACK-COLOR: #fffbff } At the post "Medical Informatics, Pharma, Health IT, and Golden Advice That Sits Sadly Unused" and other posts I lamented the fact that